Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB02Antihemorrhagics
- Pharmacological subgroupB02B
- Chemical subgroupB02BXOther systemic hemostatics
- Chemical substanceB02BX11Marstacimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 4 registrations
Netherlands
CBG-MEB · 2 registrations
Brazil
Anvisa · 1 registration
At a glance
- ATC code
- B02BX11
- ATC group
- Blood and blood-forming organs
- Registers
- 7
- Registrations
- 11
- With their own page
- 11
- Companies
- 4
All medicines with Marstacimab
Human medicines from every register that match Marstacimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
11 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Hympavzi | United States | 75MG/0.5ML | Injection | Marketed | Pfizer Inc. |
| Hympavzi | United States | 150MG/ML | Injection | Marketed | Pfizer Inc. |
| Hympavzi | United States | 300MG | injectable | Marketed | Pfizer INC |
| Hympavzi | United States | 75MG/0.5ML | Injection | Marketed | Pfizer Inc. |
| Hympavzi 150 MG Solucion Inyectable en Pluma Precargada | Spain | 150 mg | solución inyectable en pluma precargada | Marketed | Pfizer Europe Ma Eeig |
| Hympavzi | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Hympavzi 150 mg oplossing voor injectie in een voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | Pfizer Europe MA EEIG | |
| Hympavzi 150 mg oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Pfizer Europe MA EEIG | |
| Hympavzi Solution for Injection in Single-Dose Pre-Filled Pen 150 MG/ML | Singapore | 150 mg/ml | injection, solution | Authorised | Pfizer Private Limited |
| Hympavzi | Brazil | Authorised | Pfizer Brasil Ltda | ||
| Hympavzi | Croatia | Authorised |